FDA label
What is Alecensa used for?
Alecensa contains alectinib. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label for Alecensa lists 2 uses: Adjuvant Treatment of Resected ALK-Positive Non-Small Cell Lung Cancer (NSCLC); Treatment of Metastatic ALK-Positive NSCLC.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Alecensa?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Alecensa, capsule
Indications and Usage, quoted from the label by Genentech, Inc. (NDA208434). Cross-references to other label sections are left out.
Adjuvant Treatment of Resected ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
ALECENSA is indicated as adjuvant treatment in adult patients following tumor resection of anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) (tumors ≥ 4 cm or node positive), as detected by an FDA-approved test.
Treatment of Metastatic ALK-Positive NSCLC
ALECENSA is indicated for the treatment of adult patients with ALK-positive metastatic NSCLC as detected by an FDA-approved test.
Source: DailyMed label, set id 42c49deb-713b-427a-9670-08af08adcffb, version 29, effective August 21, 2026. NDC 50242-130, one of 1 listing for this product.
Questions
What is Alecensa used for?
The FDA label for Alecensa lists 2 uses: Adjuvant Treatment of Resected ALK-Positive Non-Small Cell Lung Cancer (NSCLC); Treatment of Metastatic ALK-Positive NSCLC.
What drug class is Alecensa?
FDA lists alectinib in the Kinase Inhibitor established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.